We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Surveillance Trial Offers Peace of Mind for High-risk BRCA-carriers

News   Aug 23, 2018 | Original story sourced from University College Hospitals London

 
Avoiding Late Diagnosis of Ovarian Cancer

The ALDO (Avoiding Late Diagnosis of Ovarian Cancer) project is a partnership between UCLH Cancer Collaborative and Abcodia Ltd. The project was conceived as part of the Cancer Vanguard’s challenge to industry in 2017, to work with the NHS on projects to improve the early diagnosis of cancer. Photo credit: Pixabay

 
 
Advertisement
 

RELATED ARTICLES

Blood Test Could Diagnose Baby Brain Damage Just Hours After Birth

News

A newly developed blood test could detect which babies deprived of oxygen at birth are at risk of serious neurodisabilities like cerebral palsy and epilepsy.

READ MORE

Circulating DNA From Tumor Could Predict Immunotherapy Outcome

News

A newly developed test that detects changing levels of tumor fragments in the blood may be an easy, non-invasive and quick way to predict who will benefit from immunotherapy, according to researchers.

READ MORE

Team Reveals How Abnormal Protein Disrupts Gene Expression in Synovial Sarcoma

News

A team has discovered how an abnormal protein misdirects and disrupts the control of gene expression in cells, causing the aberrant activation of genes that drive the growth of sarcoma tumors.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE